ALK and non-small cell lung carcinoma: To find novel targets that promote cell survival in ALK+ NSCLC cells subjected to ALK inhibition, we first established a cell line (ALK1903 cells) with cells from an ALK‐TKI treatment‐naïve ALK+ NSCLC patient.